GGrantIndex
← Leaderboards

Lurie Children'S Hospital Of Chicago

Chicago, IL

Compare ↔
$336,114,918
Total funding
279
Grants

Funding over time

peak $37.8M · FY2006–25
$50M$37.5M$25M$12.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$310,365,247 · 259
CDC$18,849,592 · 14
FDA$4,250,000 · 2
AHRQ$2,650,079 · 4

By mechanism

R01$173,265,737 · 93
U01$67,822,833 · 23
R21$16,707,837 · 44
K23$16,033,997 · 28
K08$9,737,318 · 21
R37$6,515,260 · 3

Investigators at Lurie Children'S Hospital Of Chicago

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Wendy J Brickman$2,830,0241 gr2Emilie Katherine Johnson$1,191,7141 gr3Elan Hope$788,5911 gr4Hayk Barseghyan$736,3671 gr5Miriam A. Bornhorst$736,3671 gr6Xiaocai Yan$431,7501 gr7Ramille Shah$217,7081 gr

Emerging Leaders

6–10 yrs in

1Jami L Josefson$5,049,6892 gr2Lazaro Nelson Sanchez-Pinto$4,349,8716 gr3Diane Chen$3,105,2245 gr4Bria M Coates$2,696,2292 gr5Carlos Enrique Prada$2,577,6932 gr6Monica M Laronda$2,568,6153 gr7Daniel T. Robinson$2,359,2582 gr8Amanda K Marma$2,142,7623 gr

All-Time

Most funded here, all years

1Joseph Randall Moorman$11,377,3546 gr2Namasivayam Ambalavanan$8,959,9698 gr3Sunjay Kaushal$7,474,2694 gr4Ann Harris$7,048,7974 gr5Jami L Josefson$5,049,6892 gr6Anna Maria Hibbs$4,843,7353 gr7Todd Adam Florin$4,787,9513 gr8Christine Didonato$4,611,4064 gr

Largest grants

Category A - Communities Putting Prevention to Work$5,800,000
U58 · FY2010 · DP
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$3,894,611
U01 · FY2022 · DK
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$3,678,947
U01 · FY2024 · DK
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$3,664,418
U01 · FY2021 · DK
Units for HIV/AIDS Clinical Trials Networks$2,310,776
U01 · FY2007 · AI
Regulation of mitochondrial DNA homeostasis and neuroinflammation by Fascin in Alzheimer’s Disease$2,187,498
RF1 · FY2022 · AG
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$2,180,043
U01 · FY2025 · DK
Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD)$2,070,206
R01 · FY2024 · HL
Units for HIV/AIDS Clinical Trials Networks$2,016,531
U01 · FY2008 · AI
The GROWTH Study, Glycemia Range and Offspring Weight and adiposity in response To Human milk$2,007,921
R01 · FY2023 · HD
RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation$1,999,999
U01 · FY2024 · PS
RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation$1,999,998
U01 · FY2023 · PS
RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation$1,998,696
U01 · FY2025 · PS
Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH)$1,941,677
R01 · FY2023 · HL
Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD)$1,906,644
R01 · FY2025 · HL
The GROWTH Study, Glycemia Range and Offspring Weight and adiposity in response To Human milk$1,886,293
R01 · FY2024 · HD
Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH)$1,873,668
R01 · FY2025 · HL
The GROWTH Study, Glycemia Range and Offspring Weight and adiposity in response To Human milk$1,872,667
R01 · FY2025 · HD
Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH)$1,844,703
R01 · FY2024 · HL
Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden$1,843,151
R61 · FY2021 · NS